Biologics Top Stories Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan byJosh SandbergSeptember 22, 2017
Biologics Bone Therapeutics SA : Announces all Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-Union Study Interim Analysis byJosh SandbergSeptember 20, 2017